HomeHYPE3 • BVMF
add
Hypera SA
Nakaraang pagsara
R$22.91
Sakop ng araw
R$22.91 - R$23.73
Sakop ng taon
R$15.94 - R$28.56
Market cap
14.51B BRL
Average na Volume
2.88M
P/E ratio
19.69
Dividend yield
2.17%
Primary exchange
BVMF
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (BRL) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.15B | -1.60% |
Gastos sa pagpapatakbo | 649.05M | 0.84% |
Net na kita | 426.69M | -13.42% |
Net profit margin | 19.81 | -11.99% |
Kita sa bawat share | 0.68 | -12.82% |
EBITDA | 694.71M | -2.19% |
Aktuwal na % ng binabayarang buwis | 1.82% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (BRL) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.20B | -57.56% |
Kabuuang asset | 24.24B | -4.47% |
Kabuuang sagutin | 12.24B | -8.25% |
Kabuuang equity | 11.99B | — |
Natitirang share | 632.94M | — |
Presyo para makapag-book | 1.21 | — |
Return on assets | 6.65% | — |
Return on capital | 7.63% | — |
Cash Flow
Net change in cash
| (BRL) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 426.69M | -13.42% |
Cash mula sa mga operasyon | 442.78M | -29.06% |
Cash mula sa pag-invest | -209.22M | -72.00% |
Cash mula sa financing | -770.05M | 8.42% |
Net change in cash | -536.50M | -58.58% |
Malayang cash flow | -42.79M | -121.30% |
Tungkol
Hypera Pharma is a Brazilian multinational pharmaceutical
company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
10,481
